Postmenopausal hormone therapy was cost-effective when started at age 50 years but not at 65 years

Johnson, Bruce E.; Johnson, Cynda Ann
June 2009
ACP Journal Club;6/23/2009, Vol. 150 Issue 6, p13
Academic Journal
The article discusses the cost-effectiveness of hormone therapy (HT) in postmenopausal women. The details of a clinical trial involving two hypothetical cohorts of healthy postmenopausal women aged 50 and 65 years are presented. The researchers found that, hormone therapy increased quality-adjusted life-years in healthy postmenopausal women and was cost-effective when started at age 50 years but not when started at age 65 years.


Related Articles

  • HORMONE REPLACEMENT, BIO-IDENTICAL AND CONVENTIONAL - where are we in 2009? Enstein, Michael // Australian Advanced Aesthetics;Sep2009, Issue 3, p44 

    The article discusses the conventional hormone replacement therapy (HRT) which is being considered safe for women in their early post-menopausal period. It looks into the findings of the Women's Health Initiative Trial (WHI) on the recommendation of the HRT to treat women during their...

  • A Faithful Subject. Elber, Gail // Applied Clinical Trials;Oct2002, Vol. 11 Issue 10, p64 

    Presents subjects' perception of a clinical trial to improve the health of postmenopausal women. Reasons why women are hesitant to participate on the trial; Hormone replacement therapy; Medical problems during the trial.

  • Hormone Therapy Update. Vanderhaeghe, Lorna // Alive: Canada's Natural Health & Wellness Magazine;Jul2003, Issue 249, p8 

    Focuses on the dangers of hormone replacement therapy (HRT), the combination of synthetic estrogen and progestins. Percentage of Canadian women using HRT who have abandoned the process in 2002; Issue of quality of life outcomes.

  • Effects of hormone therapy on quality of life in postmenopausal women with CAD differed according to menopausal symptoms. Haynes, Joan // ACP Journal Club;Nov/Dec2002, Vol. 137 Issue 3, p105 

    Discusses research being done on the effects of hormone therapy on the health-related quality of life in postmenopausal women with coronary artery disease. Reference to study by M.A. Hlatky and colleagues, published in the February 2002 issue of the 'Journal of American Medical Association';...

  • Long-term HRT cost effective in Finland.  // PharmacoEconomics & Outcomes News;3/24/2007, Issue 524, p12 

    The article discusses research being done on long-term use of continuous combined hormone replacement therapy (HRT) for treating menopausal symptoms in women in Finland. It references a study by S. Ylikangas and colleagues published in the January 2007 issue of "Current Medical Research and...

  • More About the WHI. Napoli, Maryann // HealthFacts;May2004, Vol. 29 Issue 5, p3 

    Reports on the Women's Health Initiative, a U.S. government-funded clinical trial in which healthy postmenopausal women had been randomly assigned to take hormones or a placebo. Percentage of participants who had taken hormone drugs prior to the trial; Number of participants who do not have a...

  • US estrogen plus progestin HRT trial stopped due to increased risk of breast cancer, stroke and heart attack. Sibbald, Barbara // CMAJ: Canadian Medical Association Journal;8/6/2002, Vol. 167 Issue 3, p294 

    Reports that a U.S. trial of the risks and benefits of combined estrogen and progestin in healthy menopausal women has been stopped because long-term use increases the risk of breast cancer, stroke, and heart attacks. Benefits of the hormone therapy, including fewer hip fractures; Details of...

  • Oestrogen does not improve quality of life for postmenopausal women after hysterectomy. Brunner, R. L. // BMJ: British Medical Journal (International Edition);10/22/2005, Vol. 331 Issue 7522, p915 

    The article mentions a study on the effect of hormone replacement therapy (HRT) with estrogen on the quality of life for postmenopausal women who have had hysterectomies. The trial "Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy"...

  • Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women. Mattsson, L. A.; Skouby, S.; Rees, M.; Heikkinen, J.; Kudela, M.; Stadnicki-Kolendo, A.; Mattila, L.; Salminen, K.; Vuorela, A.; Mustonen, M. // Menopause International;Sep2007, Vol. 13 Issue 3, p124 

    Objective. Continuous combined hormone replacement therapy (ccHRT) based on estradiol valerate (E2V) and medroxyprogesterone acetate (MPA) is effective for relief of menopausal symptoms three years or more after the menopause. This study was undertaken to examine the efficacy and tolerability of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics